GFAP and diabetic neuropathy: A study evaluating circulating GFAP and UCH-L1 levels in patients with and without diabetic polyneuropathy (DPN) found that serum GFAP levels were significantly reduced in individuals with DPN compared to controls and those without DPN [340].